PC3I News
The Cancer Service Line (CSL) and the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center (ACC) are excited to announce the selection of the 2024 Penn Cancer Innovation Accelerator project, EASE: rEimagining cAncer SchEduling.
Katie Boyk, BS, MHA, the Associate Director of Operations for the Cancer Service Line submitted the winning proposal, which outlined the complex operational challenges that affect scheduling for cancer patients, especially those in active treatment. For example, an individual patient about to start a new chemotherapy regimen often needs not only infusion appointments – the length of which depends on the specific regimen – but also blood draws, provider appointments, and imaging. All of these ancillary appointments have complex sequencing and timing involved. The current process for communicating these scheduling needs is overly manual and too often causes downstream operational challenges and frustration for patients and clinicians alike.
As part of the Accelerator program, PC3I will partner with Katie to build an interdisciplinary, cross-functional project team from across Penn Medicine. With oversight and guidance from the CSL/PC3I leadership group, the project team will spend the next 6-9 months focused on fully diagnosing this problem and proposing innovative solutions. Drawing on PC3I’s expertise in design thinking, behavioral change, and clinical transformation, the project aims to redesign the cancer scheduling process to prioritize both patient-centeredness and operational efficiency.
Each year, the Penn Cancer Innovation Accelerator program invites applications from across Penn Medicine to create and test innovative solutions for challenges in cancer care at Penn. Past projects include:
Related News
PC3I News
PC3I and Tennessee Oncology’s McKay Institute for Oncology Transformation Unveil New Collaborative Relationship
02.06.2024
PC3I and Tennessee Oncology’s McKay Institute for Oncology Transformation announce an academic-community oncology innovation partnership to improve cancer care delivery.
PC3I News
PC3I Leadership Presents at 2023 AORTIC International Conference on Cancer in Africa
12.05.2023
PC3I Associate Director Surbhi Grover and Deputy Director Katharine Rendle presented research at the 14th AORTIC International Conference on Cancer in Africa, which took place in Dakar, Senegal.
PC3I News
2024 PC3I Innovation Accelerator Request for Proposals
11.10.2023
Through the Innovation Accelerator, the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center (ACC) invite applications for initiatives that aim to create and test innovative solutions to address challenges in productivity, efficiency, clinician wellbeing, or access in cancer care at Penn Medicine